During the past decade, Central Texas Veterans Health Care System, Temple, TX conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 16 clinical trials were completed, i.e. on average, 114.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Texas Veterans Health Care System, Temple, TX" #1 sponsor was "VA Office of Research and Development" with 17 trials, followed by "US Department of Veterans Affairs" with 6 trials sponsored, "Celgene" with 2 trials sponsored, "Aptevo Therapeutics" with 1 trials sponsored and "Bavarian Nordic" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Texas Veterans Health Care System, Temple, TX" #1 collaborator was "Central Texas Veterans Health Care System" with 3 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator, "Texas A&M University" with 2 trials as a collaborator, "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator and "Boston University" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Central Texas Veterans Health Care System, Temple, TX" are "Moral Injury" (3 trials), "Schizophrenia" (3 trials), "Bipolar Disorder" (2 trials), "Depression" (2 trials) and "Depressive Disorder" (2 trials). Many other conditions were trialed in "Central Texas Veterans Health Care System, Temple, TX" in a lesser frequency.

Most popular intervention types in "Central Texas Veterans Health Care System, Temple, TX" are "Behavioral" (10 trials), "Drug" (8 trials), "Device" (4 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Lenalidomide" (2 trials), "Adaptive Disclosure for Moral Injury and Loss" (1 trials), "Augmenting: Antidepressant + Aripiprazole" (1 trials) and "Augmenting: Antidepressant + Bupropion-SR" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Texas Veterans Health Care System, Temple, TX" are 27 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Central Texas Veterans Health Care System, Temple, TX". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Central Texas Veterans Health Care System, Temple, TX, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Central Texas Veterans Health Care System, Temple, TX, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 12 trials that are defined as “Not Applicable".